Cardiac Magnetic Resonance and Positron Emission Tomography in the Diagnosis and Follow-Up of Acute Rheumatic Fever - Case Report

Keywords
Rheumatic Fever/physiopathology; Epidemiology; Rheumatic Heart Disease; Diagnostic Imaging; Magnetic Resonance Spectroscopy/methods; Positron Emission Tomogaphy Computed Tomography/methods

Introduction

Rheumatic fever (RF) is a prevalent condition in developing countries, accounting for a cardiac mortality of rate 7.9% in Brazil (DATASUS).¹ Cases of rheumatic fever are often underdiagnosed and recognized only after permanent valve damage due to previous carditis.² Secondary prevention of RF aims to limit the development and/or progression of valvular lesions and their complications. However, even on therapy with benzathine penicillin every 21 days, patients may experience recurrence of acute RF, making diagnosis a greater challenge. The development of new diagnostic methods can contribute to the early detection of rheumatic carditis (RC) considering that 90% of cases are subclinical.³ In addition, not only the usual gallium-67 scintigraphy, but also, tests such as cardiac nuclear magnetic resonance imaging (MRI) and positron emission tomography (PET-CT) may have the potential to be diagnostic tools in acute rheumatic carditis. However, more studies are needed to validate these methods.¹ , ²

Case Report

A 23 years-old woman was admitted with a history of permanent atrial fibrillation, cardiac sequelae of RF and four cardiac surgeries (mitral, aortic and tricuspid valve repair in 2006 and 2007; aortic valve replacement with biological prosthesis in 2011, and mitral valve replacement with a biological prosthesis in the 2014). The patient has been treated with benzathine penicillin for secondary prophylaxis. Two years before, the patient was admitted to the emergency room with New York Heart Association functional class II. She had signs of right and left congestion, aortic systolic murmur, tricuspid regurgitation murmur, and silent mitral auscultation. A transthoracic echocardiogram (TTE) revealed decreased left ventricular ejection fraction (LVEF) (from 56% to 26%), and mitral and aortic prosthesis dysfunction. The hypothesis of recurrence of acute RF was made mainly because of the reduction in LVEF. There was evidence of inflammatory activity (leukocytes 13620/mm,³ erythrocyte sedimentation rate of 36 mm/h, lactic dehydrogenase 297 U/ml, C-reactive protein 2.5 mg/L). A gallium-67 scintigraphy revealed increased concentration of the radiopharmaceutical in the cardiac area, with a diffuse pattern of uptake ( Figure 1 ). Oral prednisone (1mg per kilogram per day) was started with good clinical response. MRI was conducted 72 hours after initiation of steroids, which showed LVEF of 44%, non-ischemic focal myocardial fibrosis with native T1 and extracellular volume, leading to the hypothesis of inflammatory cardiomyopathy ( Figure 2 ). Seven days after prednisone, another TTE showed a significant improvement in LVEF, to 50%. Then, a fluorodeoxyglucose-(18F-FDG) PET-CT was performed, which confirmed myocardial uptake ( Figure 3 ). Finally, the patient was discharged to finish corticosteroid therapy and referred for elective mitral and aortic valve replacement.

Figure 1
Cardiac scintigraphy obtained in the anterior view of the chest (72 hours after administration of the radiopharmaceutical), showing gallium-67 diffuse uptake in the cardiac area graded as mild to moderate.

Figure 2
Cardiac Nuclear Magnetic Resonance imaging showing inferoseptal junctional focal fibrosis of non-ischemic pattern suggestive of inflammatory cardiomyopathy (arrow). The myocardial native T1 was 903 ms, and the normal value for sequence to map T1 was 950-1050 ms. The imaging was performed using 1.5-T scanner.

Figure 3
PET-CT using fluorine-18 (18F-FDG) without myocardial uptake; 145x179mm (96 x 96 DPI).

Discussion and Conclusion

RF is more prevalent in low- and middle-income countries, reflecting the low level of primary preventive care especially in children and young adults.⁴ In Brazil, there are about 30,000 new cases of RF per year, of which approximately 15,000 may have cardiac involvement. Cardiac complications are the most feared complications of RF due to their chronic and sometimes disabling sequelae.⁵ RF is an often underdiagnosed condition since when a patient needs surgery it reflects an infection which occurred 10 or 20 years before.⁶ Medical diagnostic is challenging, as there is no gold-standard complementary test available to confirm an acute RF case.

RC can present as mild, moderate or severe disease. Besides, the most frequent presentation is subclinical which is defined as a functional or structural change in the heart, seen on echocardiography, consistent with rheumatic heart disease, many times in the absence of a pathological heart murmur.⁷

There are diagnostic imaging methods that are useful to define a suspected RF carditis. Currently, endomyocardial biopsy, an invasive test with reduced sensitivity, is less used.⁸ Scintigraphy with gallium 67, cardiac magnetic resonance and positron emission tomography (PET-CT) are important complementary tools.

Recent studies have evaluated the use of gallium scintigraphy in the diagnosis and prognosis of this disease and shown a high sensitivity (91-100%) of the method.⁹ , ¹⁰ Gallium scintigraphy allows the detection of RC activity and therapeutic follow-up and has its best diagnostic performance in the first three months of clinical presentation. In addition, it is a reliable method to distinguish acute from chronic and inactive RC.¹¹ PET-CT, despite its low sensitivity, has shown a positive predictive value close to 100. Finally, cardiac MRI has shown an 85% accuracy. Both methods have great potential to become standard tests for the diagnosis of acute RC.¹¹ – ¹⁴

This case report demonstrates that PET-CT and MRI are useful tests to diagnose acute RC. These recent imaging tools could not only establish the diagnosis, but also assess the effectiveness of the treatment. Gallium scintigraphy was also essential to reveal the cardiac inflammatory process, which was confirmed by MRI findings, suggesting inflammatory cardiomyopathy. In this context, PET-CT was used as a control test after treatment.

In this case report, we demonstrated the importance of multiple diagnostic imaging tools to early diagnose RF carditis, particularly after an unexpected reduction in the LVEF in a patient with valvular heart disease.

In conclusion, similarly to gallium-67 scintigraphy, MRI and PET-CT can be of high value in the diagnosis and follow-up of acute or recurrent RF.

• Sources of Funding
  There were no external funding sources for this study.
• Study Association
  This study is not associated with any thesis or dissertation work.
• Ethics approval and consent to participate
  This article does not contain any studies with human participants or animals performed by any of the authors.

References

• ¹
  Lemos F, Haddar G, Sobrinho C, Thebit M. Evolutive Study of Rheumatic Carditis Cases Treated with Corticosteroids in a Public Hospital. Int. J. Cardiovasc. Sci.2019;31(6):578-84. DOI: 10.5935/2359-4802.20180059
  » https://doi.org/10.5935/2359-4802.20180059
• ²
  Marijon E, Phalla O, Celermajer D, Ferreira B, Mocumbi A, Jani D, et al. Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening. N Engl J Med. 2007;3575:470-6. doi: 10.1056/NEJMoa065085.
  » https://doi.org/10.1056/NEJMoa065085
• ³
  De Dassel JL, Ralph AP, Carapetis JR. Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer? Curr Opin Pediatr. 2015 Feb;27(1):116- 23. DOI: 10.1097/MOP.0000000000000164
  » https://doi.org/10.1097/MOP.0000000000000164
• ⁴
  Carapetis, J, Steer A, Mulholland E, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005 Nov;5(11):685-94. DOI: 10.1016/S1473-3099(05)70267-X
  » https://doi.org/10.1016/S1473-3099(05)70267-X
• ⁵
  Barbosa P, Müller R, Latado A, Achutti A, Ramos A, Weksler C, et al. Diretrizes Brasileiras para Diagnóstico, Tratamento e Prevenção da Febre Reumática da Sociedade Brasileira de Cardiologia, da Sociedade Brasileira de Pediatria e da Sociedade Brasileira de Reumatologia. Arq Bras Cardiol.2009;93(3 supl.4):1-18. DOI: 10.1016/S1473-3099(05)70267-X
  » https://doi.org/10.1016/S1473-3099(05)70267-X
• ⁶
  Spina G. Doença reumática: negligenciada, mas ainda presente e mortal. Rev Med (São Paulo). 2008 abr-jun.;87(2):128-41.
• ⁷
  Branco C, Sampaio R, Bracco M, Morhy S, Vieira M, Guilherme L, et al. Febre Reumática: Doença Negligenciada e Subdiagnosticada. Novas Perspectivas no Diagnóstico e Prevenção. Arq Bras Cardiol. 2016; 107(5):482-4. doi: 10.5935/abc.20160150.
  » https://doi.org/10.5935/abc.20160150
• ⁸
  Xavier J, Soeiro A, Lopes A, Spina G, Serrano C, Oliveira M. Miocardite Clinicamente Manifesta em Surto Agudo de Febre Reumatica. Arq. Bras. Cardiol. 2014; 102(2): e17-20. doi: 10.5935/abc.20140017.
  » https://doi.org/10.5935/abc.20140017
• ⁹
  Javadi, H, Jallalat S, Pourbehi G, Semnani S, Mogharrabi M, Nabipour I, et al. The role of gated myocardial perfusion scintigraphy (GMPS) in myocarditis: A case report and review of the literature. Nucl Med Rev Cent East Eur. 2011;14(2):112-5. DOI: 10.5603/nmr.2011.00026
  » https://doi.org/10.5603/nmr.2011.00026
• ¹⁰
  Calegaro J, Carvalho A, Campos E; Medeiros M, Gomes E. Gallium-67 in Rheumatic Fever: Preliminary Report. Arq Bras Cardiol. 1991 Jun;56(6):487-92. PMID: 1823751
• ¹¹
  Soares J, Snitcowsky R, Meneghetti J, Hironaka F, Assis R, Giorgi M, et al. Gallium-67 imaging in the diagnosis and follow-up of rheumatic carditis. Eur J Nucl Med. 1990;16:S5.
• ¹²
  Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: Comparison of different approaches. J Am Coll Cardiol. 2005 Jun 7;45(11):1815-22. doi: 10.1016/j.jacc.2004.11.069.
  » https://doi.org/10.1016/j.jacc.2004.11.069
• ¹³
  Chamarajnagar M, Saxena A, Patel C, Karunanithi S, Nadig M, Malhotra A, et al. The role of 18F fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in children with rheumatic carditis and chronic rheumatic heart disease. Nucl Med Rev Cent East Eur. 2015;18(1):25-8. doi: 10.5603/NMR.2015.0006.
  » https://doi.org/10.5603/NMR.2015.0006
• ¹⁴
  Uygur B, Celik O, Ustabasioglu F, Akinci O, Erturk M. Three-dimensional transesophageal echocardiography vs cardiac magnetic resonance in the assessment of planimetric mitral valve area in rheumatic mitral stenosis. Echocardiography. 2018;35(10):1621-5. doi: 10.1111/echo.14096.
  » https://doi.org/10.1111/echo.14096

Publication Dates

• Publication in this collection
  22 Apr 2022
• Date of issue
  2023

History

• Received
  17 Mar 2021
• Reviewed
  20 July 2021
• Accepted
  27 Nov 2021